Literature DB >> 12534964

The mouse MPTP model: gene expression changes in dopaminergic neurons.

Kati Kühn1, Jennifer Wellen, Nina Link, Lyutha Maskri, Hermann Lübbert, Christine C Stichel.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the substantia nigra. Although valuable animal models have been developed, our knowledge of the aetiology and pathogenic factors implicated in PD is still insufficient to develop causal therapeutic strategies aimed at halting its progression. The neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is one of the most valuable models for analysing pathological aspects of PD. In this paper we studied the gene expression patterns underlying the pathogenesis of MPTP-induced neurodegeneration. We treated young and old C57BL/6 mice with different schedules of MPTP to induce degenerative processes that vary in intensity and time-course. During the first week after intoxication we used nonradioactive in situ-hybridization to investigate the expression patterns of genes associated with (i) dopamine metabolism and signalling; (ii) familial forms of PD; (iii) protein folding and (iv) energy metabolism. MPTP injections induced different severities of neuronal injury depending on the age of the animals and the schedule of administration as well as a significant degeneration in the striatum. In situ hybridization showed that MPTP intoxication initiated a number of gene expression changes that (i) were restricted to the neurons of the substantia nigra pars compacta; (ii) were correlated in intensity and number of changes with the age of the animals and the severity of histopathological disturbances; (iii) displayed in each a significant down-regulation by the end of one week after the last MPTP injection, but (iv) varied within one MPTP regimen in expression levels during the observation period. The subacute injection of MPTP into one-year-old mice induced the most severe changes in gene expression. All genes investigated were affected. However, alpha-synuclein was the only gene that was exclusively up-regulated in MPTP-treated animals displaying cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534964     DOI: 10.1046/j.1460-9568.2003.02408.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  33 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

2.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

Review 3.  Agrochemicals, α-synuclein, and Parkinson's disease.

Authors:  Blanca A Silva; Leonid Breydo; Anthony L Fink; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-08-30       Impact factor: 5.590

Review 4.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

5.  A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.

Authors:  Akane Hayashi; Naoya Matsunaga; Hiroyuki Okazaki; Keisuke Kakimoto; Yoshinori Kimura; Hiroki Azuma; Eriko Ikeda; Takeshi Shiba; Mayumi Yamato; Ken-Ichi Yamada; Satoru Koyanagi; Shigehiro Ohdo
Journal:  Neuromolecular Med       Date:  2013-01-05       Impact factor: 3.843

6.  Time course of degeneration of dopaminergic neurons and respective compensatory processes in the nigrostriatal system in mice.

Authors:  A A Kolacheva; E A Kozina; E V Volina; M V Ugryumov
Journal:  Dokl Biol Sci       Date:  2014-07-02

7.  Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.

Authors:  Hamid Y Qureshi; Hemant K Paudel
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

8.  Motor Neurons Pathology After Chronic Exposure to MPTP in Mice.

Authors:  Giorgio Vivacqua; Francesca Biagioni; Carla L Busceti; Michela Ferrucci; Michele Madonna; Larisa Ryskalin; Shun Yu; Loredana D'Este; Francesco Fornai
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

9.  GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Isabel Peixeiro; Elsa Rodrigues; Maria Celeste Lechner; Maria João Gama
Journal:  J Mol Neurosci       Date:  2008-09-16       Impact factor: 3.444

10.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

Authors:  Vellareddy Anantharam; Elin Lehrmann; Arthi Kanthasamy; Yongjie Yang; Probal Banerjee; Kevin G Becker; William J Freed; Anumantha G Kanthasamy
Journal:  Neurochem Int       Date:  2007-02-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.